Fact CheckerSign in

NCT04004494Completed

3D Reconstruction in Video-assisted Thoracoscopic Surgery (VATS) Segmentectomy

Three-dimensional Computed Tomography Reconstruction for Operative Planning in VATS Segmentectomy

Source: ClinicalTrials.gov · Last updated 24 May 2024

Brief summary (registry, in English)

Anatomical variations of pulmonary vessel may cause serious problems during pulmonary segmentectomy. Three-dimensional (3D)computed tomography (CT) presents 3D images of pulmonary vessels and the tracheobronchial tree and may help operative planning. Retrospective studies have identified the importance of 3-dimensional CT in the field of pulmonary segmentectomy. And the aim of this study is to compare the usefulness of 3-dimensional CT with standard chest CT in preoperative planning of video-assisted segmentectomy.

Status (registry)
Completed
Study type
Interventional
Enrollment
191 (actual)
First submitted
23 Jun 2019
Start date
1 Jul 2019
Primary completion date
31 Oct 2023
Lead sponsor
Ruijin Hospital
Diseases
Lung cancer
NCT number
NCT04004494

What you commit to

  • Study type: Interventional
  • Participants enrolled: 191
  • From 1 Jul 2019 to the primary completion date, 31 Oct 2023
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with a significant medical condition which is thought unlikely to tolerate the surgery. For example, cardiac disease, significant liver and renal function disorder.
  • Patients with psychiatric disease who are expected lack of compliance with the protocol.
  • Patients have history of chest trauma or surgery on ipsilateral chest which may cause pleural adhesion.

Who the study is looking for

  • Age older than 18 years;
  • Pulmonary nodules or ground glass opacification (GGO) found in chest CT examination, and conform with indications for segmentectomy:
    • Peripheral nodule 0.8-2 cm with at least one of the following:
    • Histology of adenocarcinoma in situ; ii. Nodule has ≥50% ground-glass appearance on CT; iii. Radiologic surveillance confirms a long doubling time (≥400 days). Segmentectomy should achieve parenchymal resection margins ≥2 cm or ≥ the size of the nodule.
  • Adequate cardiac function, respiratory function, liver function and renal function for anesthesia and VATS segmentectomy.
  • American Society of Anesthesiologists (ASA) score: Grade I-III.
  • Patients who can coordinate the treatment and research and sign the informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Union Hospital of Fujian medical university
Coordinator of this site? Confirm its status
FujianChinaUnknown status
Guangdong General Hospital
Coordinator of this site? Confirm its status
GuangdongChinaUnknown status
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.